跳至主要内容
临床试验/IRCT201412163106N21
IRCT201412163106N21已完成未知

Investigation effects of Tamsulosin on disturbing dreams and nightmares: a cross over pilot study

Islamic azad university of pharmaceutical sciense0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • 1. Nightmare disorder Patients who are interested in treatment and earn necessary score on disturbing dreams and nightmares severity index (DDNSI) questionnaire; 2. No concomitant disease that limit the use of tamsulosin; 3. Quality of life and sleep impairment make drug therapy beneficial; 4. No concomitant drug therapy which have life threatening interactions with tamsulosin
  • Exclusion criteria: 1. Patients who have a low blood pressure occurrence serious side effect; 2. Patients who are not interested for treatment; 3. Patients who have sensitivity to sulfa drugs and tamsulosin or ingredients; 4. Occurrence of serious side effect like severe orthostatic hypotension; 5. Patients with cardiovascolar disease.

排除标准

  • 未提供

研究者

发起方
Islamic azad university of pharmaceutical sciense

相似试验